Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

About this update from Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:0in; } .prngen2{ PADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt } .prnml4{ MARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT } .prnbcc{ BORDER-COLLAPSE: COLLAPSE } Canada NewsWire MISSISSAUGA, ON , Oct. 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial results for the third quarter of 2025 after the market close on Thursday, November 6, 2025 . The Company will also hold a conference call on Friday, November 7, 2025 at 8:30am ET to discuss the results and corporate developments. CONFERENCE CALL DETAILS DATE: Friday, November 7, 2025 TIME: 8:30 a.m. ET DIAL-IN NUMBER: 416-945-7677 or 888-699-1199 REPLAY: 289-819-1450 or 888-660-6345 Code: 24367# Expires: November 14, 2025 WEBCAST: https://app.webinar.net/gWN6RVqwnle About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit  www.cipherpharma.com . SOURCE Cipher Pharmaceuticals Inc. View original content: http://www.newswire.ca/en/releases/archive/October2025/29/c0782.html

View stock analysis, news, and events for Cipher Pharmaceuticals Inc.